Two Sigma Investments »

Galmed Pharmaceuticals shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 24k 0.46
2023-09-30 $19k 31k 0.62

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Rivian Automotive Com Cl A Put Option (RIVN)
Carnival Corp Unit 99/99/9999 (CCL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Netflix (NFLX)
Apple (AAPL)
Visa Com Cl A (V)
Paypal Holdings (PYPL)
Pinterest Cl A (PINS)
Alphabet Cap Stk Cl A (GOOGL)
American Airls Put Option (AAL)
Bristol Myers Squibb (BMY)

View all positions for Two Sigma Investments

Top funds holding Galmed Pharmaceuticals

Walleye Trading Advisors
CVI Holdings
Two Sigma Advisers
Two Sigma Investments
Citadel Advisors
Wells Fargo & Company
TSFG
Advisor Group Holdings
Hanson McClain Advisors
Zrc Wealth Management
Bank of America Corporation

View all funds holding Galmed Pharmaceuticals